Quick Heal Technologies has accepted the resignation of Dr. Lalit Mohan Sanagavarapu as Chief Product Officer, effective August 7, 2026. The company disclosed the change in senior management to the Bombay Stock Exchange and the National Stock Exchange of India Limited, citing personal reasons for the departure. This leadership change marks the end of Dr. Sanagavarapu’s tenure in a key product role within the cybersecurity firm.

The intimation was issued in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing also references SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Vikram Dhanani, Compliance Officer at Quick Heal Technologies, signed the disclosure on August 7, 2026.

Resignation Details

Dr. Sanagavarapu tendered his resignation following a discussion with company leadership on June 8, 2026. In his resignation letter addressed to Kailash, he described the decision as difficult but necessary due to personal reasons. He acknowledged the trust placed in him by the leadership team and expressed appreciation for the autonomy and support received during his tenure.

Regulatory Disclosures

The company provided requisite disclosures as per the regulatory framework, including Annexure I detailing the event and Annexure II containing the resignation letter. No other material reasons were cited beyond personal grounds. The filing confirmed that there are no pending directorships or committee memberships requiring additional disclosure in this context.

Quick Heal Technologies reported a narrowed net loss of ₹5.3 crore for the quarter ended June 30, 2026 (Q1FY27), as higher other income partially offset a 21.4% year-on-year revenue decline to ₹45.0 crore. The cybersecurity firm's profit after tax (PAT) improved by 4.2% compared to the ₹5.5 crore loss in the corresponding quarter of the previous year. Concurrently, the Board of Directors proposed the re-appointment of Richard Stiennon as Non-Executive Independent Director for a second term of five consecutive years, effective September 27, 2026, subject to shareholder approval at the ensuing Annual General Meeting.

The Board, meeting on July 30, 2026, approved the unaudited consolidated and standalone financial results reviewed by statutory auditors M S K A & Associates LLP with an unmodified opinion. In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with the SEBI Master Circular dated January 30, 2026, the company disclosed details of the proposed re-appointment. Mr. Stiennon, who brings over 30 years of experience in the global cybersecurity industry, is not related to any other director and is not debarred from holding office by virtue of any SEBI order.

Financial Performance

Revenue from operations fell to ₹45.0 crore in Q1FY27, down from ₹57.2 crore in Q1FY26 and ₹48.7 crore in Q4FY26. Gross margin remained robust at 98.2%, slightly below the 98.5% recorded in Q1FY26 but significantly higher than the 91.4% seen in Q4FY26. Operating costs totaled ₹61.8 crore, a reduction from ₹73.8 crore in the previous quarter, primarily due to lower sales and marketing expenses (₹20.9 crore vs ₹26.9 crore) and reduced research and development spend (₹28.1 crore vs ₹32.1 crore).

The following table summarises key financial metrics across recent quarters:

Other income surged to ₹14.1 crore in Q1FY27, up from ₹5.8 crore in Q1FY26 and ₹3.8 crore in Q4FY26, playing a critical role in narrowing the bottom-line loss. Depreciation increased to ₹3.9 crore from ₹3.0 crore in the corresponding quarter last year.

What the Numbers Show

The divergence between operating performance and net profit highlights the significant role of non-operating items in Quick Heal's current financial structure. While EBITDA deteriorated sharply to a loss of ₹17.6 crore (margin of -39.1%), the PAT loss remained contained at ₹5.3 crore due to substantial other income of ₹14.1 crore. This suggests that core operational profitability remains under pressure, with the net result heavily dependent on investment gains or other non-recurring income streams rather than operational efficiency. Furthermore, the reduction in overdues by nearly ₹70 crore since H1FY26, now standing at ₹106.6 crore, indicates improved cash collection efforts despite the revenue decline.

Strategic Developments

Harish Kumar G S, Chief Executive Officer, emphasized a focus on AI-driven cybersecurity and enterprise expansion. The company secured a multi-year order for 1.5 lakh devices from the Defence sector and added a significant Seqrite XDR customer in the banking technology space. Enterprise revenue stood at ₹30.0 crore, down 5.5% YoY, but deferred revenue rose to ₹52.3 crore from ₹33.8 crore in Q4FY26, signaling strong future revenue visibility. Additionally, the company shifted its registered office from Solitaire Business Hub to Thube Park, Shivajinagar, Pune, effective July 30, 2026, while books of accounts remain at the corporate office in Yerwada, Pune.